U.S. federal trademark · Serial No. 86931647 · Reg. No. 5043147
Promoting collaboration within the scientific, research, pharmaceutical, provider, and payer communities to accelerate the development and use of immunotherapy and genomic sequencing in cancer treatment
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.